The United Nations Special Envoy for HIV/AIDS in Africa has called on research scientists to become advocates for a vaccine against HIV, even though "the science is supernaturally complex and difficult, the exploratory investments are huge, the monetary risks are great and, undoubtedly the biggest obstacle to urgency of all, the market lies overwhelmingly in the poorest countries of the world."